← The Procter & Gamble Company
PG EPS
Net income divided by diluted shares outstanding — the per-share profit earned each quarter.
EPS
Latest: $1.26 (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $1.63 |
| 2020Q4 | $1.47 |
| 2021Q1 | $1.26 |
| 2021Q2 | $1.14 |
| 2021Q3 | $1.61 |
| 2021Q4 | $1.66 |
| 2022Q1 | $1.33 |
| 2022Q2 | $1.21 |
| 2022Q3 | $1.57 |
| 2022Q4 | $1.59 |
| 2023Q1 | $1.37 |
| 2023Q2 | $1.37 |
| 2023Q3 | $1.83 |
| 2023Q4 | $1.40 |
| 2024Q1 | $1.52 |
| 2024Q2 | $1.27 |
| 2024Q3 | $1.61 |
| 2024Q4 | $1.88 |
| 2025Q1 | $1.54 |
| 2025Q2 | $1.48 |
| 2025Q3 | $1.95 |
| 2025Q4 | $1.78 |
| 2026Q1 | $1.63 |
| 2026Q2 | $1.26 |
Other PG Charts
More quarter-by-quarter fundamentals for The Procter & Gamble Company
1 / 10
Revenue
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Consumer Comparison
1 / 3
Latest EPS: $1.26 (2026Q2); -14.9% YoY; +1.8% CAGR since 2011Q1 (15.25y).
Across the 62 quarters from 2011Q1 to 2026Q2, EPS ranged from -$2.05 in 2019Q2 to $2.88 in 2016Q4.
Chart and table show the latest 24 of 62 quarters.